Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

New IDWeek 2024 study reveals disparities in PrEP uptake across key U.S. populations. While overall PrEP usage has increased, ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

The AIDS Society of India (ASI) on Friday urged the government to include HIV self-testing and pre-exposure prophylaxis (PrEP ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...

In this randomized controlled trial, among adolescent girls and young women, it was found that twice-yearly lenacapavir ...